Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Change in Receivables (2018 - 2025)

X4 Pharmaceuticals' Change in Receivables history spans 4 years, with the latest figure at -$318000.0 for Q4 2025.

  • For Q4 2025, Change in Receivables fell 129.72% year-over-year to -$318000.0; the TTM value through Dec 2025 reached -$497000.0, down 146.45%, while the annual FY2025 figure was -$497000.0, 146.45% down from the prior year.
  • Change in Receivables reached -$318000.0 in Q4 2025 per XFOR's latest filing, down from -$254000.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $1.1 million in Q4 2024 to a low of -$561000.0 in Q1 2025.